Open innovation challenge for Sustainable materials solutions

Rubbers & plastics for the automotive industry

1 Min
More

SCIENION continues to grow and will build new headquarters in Berlin Adlershof

SCIENION AG, located in the Technology Park Adlershof since its foundation in 2001, today announced that the expanding company will build larger new headquarters at Wagner-Régeny Street in the same district of Berlin.

2 Min
More

​​​​​​​Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA

 

Eckert & Ziegler is proud to announce that it is expanding its production site in Wilmington just north of Boston, Massachusetts of a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite…

2 Min
More

GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

• Proceeds will facilitate development of GeneQuine’s gene therapy pipeline for musculoskeletal disorders and vector platform

• Lead gene therapy candidate GQ-303, a potentially disease-modifying treatment for osteoarthritis, will be advanced to…

7 Min
More

Milestones to success: how to turn research into health

Translate! A symposium hosted by the BIH Center for Regenerative Therapies on January 25 and 26

 

The mission of the Berlin Institute of Health is medical translation, which involves transferring research findings to the patient’s bedside and…

4 Min
More

ProBioGen licenses GlymaxX® Technology to AbbVie

ProBioGen AG has signed a commercial license agreement with AbbVie for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).

2 Min
More

Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care

 

Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from January 8, 2021.

Seed implantation or so…

2 Min
More

Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1

GlycoBody to be integrated into ONK pre-clinical program ONKT103, for solid tumors.

3 Min
More

Charité Dean Axel Pries to be new president of World Health Summit from 2021 on

Founder Detlev Ganten relinquishes office after 12 years

4 Min
More

Alrise announces acquisition of its ImSus® drug delivery technology by Ferring International Center S.A.

 

The drug delivery specialist Alrise Biosystems GmbH has entered into an Asset Purchase and Exclusive License Agreement with Ferring International Center S.A. for the development and commercialisation of products manufactured with Alrise’s ImSus®…

1 Min
More
Show more items